This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
After more than 13 years at Johnson & Johnson, including most recently serving a...
Kronos Bio is vacating its corporate headquarters in California amid a wider cos...
Human medicines European public assessment report (EPAR): Kisunla, donanemab, St...
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7...
Human medicines European public assessment report (EPAR): Fingolimod Accord, fin...
Human medicines European public assessment report (EPAR): Sialanar, glycopyrroni...
Composition of the Emergency Task Force (ETF) for preparedness
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Human medicines European public assessment report (EPAR): Orphacol, cholic acid,...
CHMP-CAT - D80-210 Overview to final EPAR - Rev 04.25 (Revamp)
Rules of procedure of the Emergency Task Force (ETF)
Superseded - Rules of procedure of the Emergency Task Force (ETF)
Human medicines European public assessment report (EPAR): Revestive, teduglutide...
Foreign assistance offers collective benefit — to security interests, humanitari...
Human medicines European public assessment report (EPAR): Moventig, naloxegol, D...
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagen...
Pharma group builds out American supply chains as part of preparations for poten...
THURSDAY, April 10, 2025 -- All-cause mortality increased in 2020 to 2021 natio...
SPRING HOUSE, Pa. (April 10, 2025) – Johnson & Johnson (NYSE: JNJ) today announc...
Paris, April 8, 2025. The New England Journal of Medicine (NEJM) published posit...
Novartis expects the new capacity will allow it to produce all of its key medici...